Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs-Reference-Cited by-同舟云学术

Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs

Published:2016-01 Issue:1 Volume:77 Page:65-71
ISSN:0002-9645
Container-title:American Journal of Veterinary Research
language:en
Short-container-title:American Journal of Veterinary Research

Author:

Larson Jeanne C.,Allstadt Sara D.,Fan Timothy M.,Khanna Chand,Lunghofer Paul J.,Hansen Ryan J.,Gustafson Daniel L.,Legendre Alfred M.,Galyon Gina D.,LeBlanc Amy K.,Martin-Jimenez Tomas

Publisher

American Veterinary Medical Association (AVMA)

Subject

General Veterinary,General Medicine

Reference25 articles.

1. Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.

2. Rapamycins: Mechanisms of Action and Cellular Resistance

3. Inhibitors of the mammalian target of rapamycin

4. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

5. Targeting mTOR Pathways in Human Malignancies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sirolimus on insulin dynamics in horses;Journal of Veterinary Internal Medicine;2023-02-25

2. Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells;BMC Veterinary Research;2021-12

3. Reasons for Exclusion of Apparently Healthy Mature Adult and Senior Dogs From a Clinical Trial;Frontiers in Veterinary Science;2021-06-02

4. A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer;Clinical Cancer Research;2021-03-19

5. Pharmacokinetics of long-term low-dose oral rapamycin in four healthy middle-aged companion dogs;2021-01-20